{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:07:06Z","timestamp":1789085226344,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA042813"],"award-info":[{"award-number":["R01DA042813"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA051807"],"award-info":[{"award-number":["K24DA051807"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA046309"],"award-info":[{"award-number":["K24DA046309"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RM1DA055437"],"award-info":[{"award-number":["RM1DA055437"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209235","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:38:50Z","timestamp":1701801530000},"page":"209235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic"],"prefix":"10.1016","volume":"157","author":[{"given":"Teresa","family":"L\u00f3pez-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Masyukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Starrels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209235_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2022.208946","article-title":"Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore","volume":"145","author":"Abidogun","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"6","key":"10.1016\/j.josat.2023.209235_bb0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2023.209235_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108959","article-title":"Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients\u2019 experiences in Australia","volume":"227","author":"Barnett","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209235_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1005574918294","article-title":"Disciplining addictions: The bio-politics of methadone and heroin in the United States","volume":"24","author":"Bourgois","year":"2000","journal-title":"Culture, Medicine and Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2023.209235_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"key":"10.1016\/j.josat.2023.209235_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209235_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2023.209235_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103573","article-title":"Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients\u2019 and prescribers\u2019 experiences with changes in unsupervised dosing","volume":"102","author":"Corace","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11136-010-9732-3","article-title":"Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment","volume":"20","author":"De Maeyer","year":"2011","journal-title":"Quality of Life Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugalcdep.2010.07.007","article-title":"A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting","volume":"113","author":"Deering","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209235_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209235_bb0060","series-title":"Treating opioid addiction","first-page":"197","article-title":"Enhancing treatment access and effectiveness: Toward patient-centered models of care","author":"Fox","year":"2019"},{"key":"10.1016\/j.josat.2023.209235_bb5015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102844","article-title":"Methadone maintenance treatment is swapping one drug for another, and that's why it works: Towards a treatment-based critique of the war on drugs","volume":"83","author":"Frank","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"9","key":"10.1016\/j.josat.2023.209235_bb0065","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2022.1271","article-title":"Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation","volume":"327","author":"Gomes","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2023.209235_bb0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.josat.2023.209235_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/maq.12232","article-title":"To be free and normal: Addiction, governance, and the therapeutics of buprenorphine: Addiction, governance, and buprenorphine","volume":"29","author":"Harris","year":"2015","journal-title":"Medical Anthropology Quarterly"},{"issue":"6","key":"10.1016\/j.josat.2023.209235_bb0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: Institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qualitative Health Research"},{"issue":"6","key":"10.1016\/j.josat.2023.209235_bb0085","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","article-title":"Venous access and care: Harnessing pragmatics in harm reduction for people who inject drugs: Vein care pragmatics and harm reduction","volume":"107","author":"Harris","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209235_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108655","article-title":"\u201cNo home to take methadone to\u201d: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston","volume":"135","author":"Harris","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.josat.2023.209235_bb0095","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.socscimed.2007.01.011","article-title":"Agency and dependency within treatment: Drug treatment clients negotiating methadone and antidepressants","volume":"64","author":"Holt","year":"2007","journal-title":"Social Science & Medicine"},{"issue":"2, Supplement","key":"10.1016\/j.josat.2023.209235_bb0100","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0376-8716(03)00055-3","article-title":"From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States","volume":"70","author":"Jaffe","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/00914509211058988","article-title":"Trade-offs in substitution treatment: A qualitative study of an opioid substitution therapy clinic as an enabling and a risk-environment","volume":"49","author":"Jakobsen","year":"2022","journal-title":"Contemporary Drug Problems"},{"issue":"13","key":"10.1016\/j.josat.2023.209235_bb0110","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209235_bb0115","article-title":"The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: A systematic review","volume":"2","author":"Karki","year":"2016","journal-title":"Evidence-Based Medicine & Public Health"},{"key":"10.1016\/j.josat.2023.209235_bb0120","article-title":"COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership","volume":"1\u20137","author":"Levander","year":"2021","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.josat.2023.209235_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266142","article-title":"Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials","volume":"17","author":"Lim","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2023.209235_bb0130","series-title":"Naturalistic inquiry","author":"Lincoln","year":"1985"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/oxfordjournals.bjsw.a011422","article-title":"Understanding drug-using clients\u2019 views of substitute prescribing","volume":"29","author":"Neale","year":"1999","journal-title":"British Journal of Social Work"},{"key":"10.1016\/j.josat.2023.209235_bb5020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.03.057","article-title":"Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin","volume":"189","author":"Neale","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/1609406917733847","article-title":"Thematic analysis: Striving to meet the trustworthiness criteria","volume":"16","author":"Nowell","year":"2017","journal-title":"International Journal of Qualitative Methods"},{"key":"10.1016\/j.josat.2023.209235_bb5010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108196","article-title":"Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?","volume":"122","author":"Nunes","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","article-title":"Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities","volume":"17","author":"Pasman","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2023.209235_bb5005","series-title":"Methadone Take-Home Flexibilities Extension Guidance","author":"SAMHSA","year":"2023"},{"key":"10.1016\/j.josat.2023.209235_bb0155","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2023.209235_bb5000","series-title":"Federal Guidelines for opioid treatment programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.josat.2023.209235_bb0150","series-title":"Methadone take-home flexibilities extension guidance March 16","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0160","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/08897077.2022.2060438","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: A qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb5025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jrh.12491","article-title":"Urban-Rural Disparities in Opioid Use Disorder Prevention and Response Activities: A Cross-Sectional Analysis","volume":"37","author":"Swann","year":"2021","journal-title":"The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association"},{"issue":"6","key":"10.1016\/j.josat.2023.209235_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"key":"10.1016\/j.josat.2023.209235_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108514","article-title":"Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms","volume":"132","author":"Treitler","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0175","first-page":"61","article-title":"Valuing methadone takeaway doses: The contribution of service-user perspectives to policy and practice","volume":"14","author":"Treloar","year":"2007","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.josat.2023.209235_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108154","article-title":"Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?","volume":"119","author":"Trujols","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2023.209235_bb0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/10826084.2022.2064509","article-title":"Lessons from the first wave of COVID-19 for improved medications for opioid use disorder (MOUD) treatment: Benefits of easier access, extended take homes, and new delivery modalities","volume":"57","author":"Walters","year":"2022","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209235_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13011-022-00449-3","article-title":"Navigating intersecting public health crises: A qualitative study of people with opioid use disorders\u2019 experiences during the COVID-19 pandemic","volume":"17","author":"Watson","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2023.209235_bb0195","article-title":"\u201cDon\u2019t judge a book by its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma","volume":"11","author":"Woo","year":"2017","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"S2","key":"10.1016\/j.josat.2023.209235_bb0200","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.2105\/AJPH.2022.306806","article-title":"Federal and state regulatory changes to methadone take-home doses: Impact of sociostructural factors","volume":"112","author":"Wyatt","year":"2022","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209235_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209235_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108996","article-title":"Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone","volume":"228","author":"Zhu","year":"2021","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:52:50Z","timestamp":1757433170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"alternative-id":["S2949875923002862"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209235","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209235"}}